4
Changes in Ownership
BIO-TECHNE Corp Filed Acc 0000914190-21-000195
Chief Financial Officer sold 10,000 shares at an average $456.67 ($4,566,663)
- Chief Financial Officer acquired 10,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Hippel James · Chief Financial Officer
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-12 | Exercise or conversion : show line 1 in the form | +10,000 | $106.59 | $1,065,900 | 19,137 | D |
| 2021-07-12 | Sale : show line 2 in the form | −600 | $451.07 | $270,640 | 18,537 | D |
| 2021-07-12 | Sale : show line 3 in the form | −751 | $451.95 | $339,416 | 17,786 | D |
| 2021-07-12 | Sale : show line 4 in the form | −788 | $453.21 | $357,126 | 16,998 | D |
| 2021-07-12 | Sale : show line 5 in the form | −662 | $454.15 | $300,647 | 16,336 | D |
| 2021-07-12 | Sale : show line 6 in the form | −1,773 | $455.57 | $807,717 | 14,563 | D |
| 2021-07-12 | Sale : show line 7 in the form | −527 | $456.41 | $240,527 | 14,036 | D |
| 2021-07-12 | Sale : show line 8 in the form | −1,136 | $457.79 | $520,055 | 12,900 | D |
| Open-market sales · 10,000 sh · avg $456.67 · $4,566,663 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-07-12 | Exercise or conversion : show line 15 in the form Stock Options (Right to Buy) | −10,000 | 20,000 | D |
Loading xslF345X03/edgar.xml…